Author

Kevin Fishwick

Observed names: Fishwick, K, K Fishwick, K. Fishwick, KA Fishwick

Institutions: Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne Hospital

Observed institutions: Eli Lilly (United States), Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne Hospital, Newcastle University

OpenAlex ID: A5080469840

Phase I Clinical and Pharmacokinetic Study of Pemetrexed and Carboplatin in Patients With Malignant Pleural Mesothelioma

2002 · Andy Hughes, Paula Calvert, et al. · Journal of Clinical Oncology · 147

Phase I study of temozolomide plus paclitaxel in patients with advanced malignant melanoma and associated in vitro investigations

2005 · A Azzabi, A N Hughes, et al. · British Journal of Cancer · 24

Phase I study of pharmacologically based dosing of carboplatin with filgrastim support in women with epithelial ovarian cancer.

1996 · M J Lind, S Ghazal-Aswad, et al. · Journal of Clinical Oncology · 12

Topotecan in combination with carboplatin: phase I trial evaluation of two treatment schedules

2002 · A.B. Simpson, P.M. Calvert, et al. · Annals of Oncology · 9

Phase 1 pharmacokinetic (PK) study of CT-2103 given Q2 or Q3 weeks in patients with solid tumors

2003 · MW Verrill, AV Boddy, et al. · Newcastle University ePrints (Newcastle Univesity) · 6

Pharmacological study of paclitaxel duration of infusion combined with GFR-based carboplatin in the treatment of ovarian cancer

2001 · Huw Thomas, Kevin Fishwick, et al. · Cancer Chemotherapy and Pharmacology · 6

Paclitaxel and carboplatin dose-intensity and duration of infusion in the treatment of ovarian cancer

2000 · Alan V. Boddy, MJ Griffin, et al. · UCL Discovery (University College London) · 1

Phase I study of temozolomide plus paclitaxel in patients with advanced malignant melanoma and associated in vitro investigations

2005 · A. Azzabi, A. N. Hughes, et al. · Newcastle University ePrints (Newcastle Univesity)

Phase I study to evaluate the safety, tolerability and pharmacokinetics of OSI-211 (Liposomal Lurtotecan) in combination with Carboplatin

2004 · Twelves, C, Gokul, S, et al. · UCL Discovery (University College London)

567 A phase I and pharmacokinetic study of BMS-247550 in combination with carboplatin in advanced solid malignancies

2003 · R. Plummer, D. Fyfe, et al. · European Journal of Cancer Supplements

A phase I dose escalation study of doxorubicin in combination with pemetrexed (Alimta (R), multitargeted antifolate).

2001 · AN Hughes, M Lind, et al. · UCL Discovery (University College London)

Population pharmacokinetics of CMF in the adjuvant treatment of breast cancer

1999 · MA Batey, JG Wright, et al. · UCL Discovery (University College London)

Works count: 14

Citation count: 214

H-index: 6

I10-index: 3